Olema Pharmaceuticals (OLMA) Stock: Buy, Sell, or Hold?
OLMA - Olema Pharmaceuticals, Inc. Common Stock
$10.22
-0.47 (-4.40%)
âŧ
5d:
-4.75%
30d:
-2.11%
90d:
+4.82%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When OLMA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OLMA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OLMA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: OLMA is currently trading at $10.22, which is considered fair relative to its 30-day fair value range of $10.41 to $11.40.
Technical Outlook: Technically, OLMA is in a downtrend. The price is currently testing key support at $10.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $39.30 (+284.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OLMA is in a downtrend. The price is currently testing key support at $10.09. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: The stock scores a mixed 52/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $39.30 (+284.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$10.41 -
$11.40
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
Protect Your Profits
Holding OLMA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (52/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 284.5% below Wall St target ($39.30)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$10.41 -
$11.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$10.09
Resistance Level
$11.18
Current Trend
Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.80
Wall Street Target
$39.30
(+284.5%)
Share & Embed Analysis
Last updated: September 13, 2026 12:21 PM ET
Data refreshes hourly during market hours. Next update: 1:21 PM
Data refreshes hourly during market hours. Next update: 1:21 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OLMA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$36 | 45 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$128 | 50 HOLD |
|
JSPR
Jasper Therapeutics Inc |
STRONG BUY
11 analysts |
$7 | 62 BUY |
|
RLAY
Relay Therapeutics Inc |
STRONG BUY
13 analysts |
$27 | 64 BUY |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$37 | 44 HOLD |
Advanced OLMA Option Strategies
Professional options setups generated by AI based on today's OLMA price and gamma walls.
